Interferon-induced gene expression and signaling in human hepatoma cell lines

K Melén1, P Keskinen, A Lehtonen

  • 1Department of Virology, National Public Health Institute, Helsinki, Finland. krister.melen@ktl.fi

Journal of Hepatology
|November 30, 2000
PubMed
Abstract

Insights

Interferon (IFN) signaling in liver cancer cells shows positive feedback. While IFNs upregulate antiviral genes, specific pathways require higher concentrations for activation, suggesting complex regulatory mechanisms in hepatoma cells.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Immunology

Background:

  • Interferon (IFN)-alpha is used to treat liver viral infections.
  • Molecular mechanisms of IFN action in liver cells are not fully understood.

Purpose of the Study:

  • Investigate IFN-induced gene expression and signaling pathways in human hepatoma cell lines (HepG2 and HuH7).

Main Methods:

  • Studied IFN-induced gene expression and signaling in HepG2 and HuH7 cells.
  • Analyzed the Janus kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway.
  • Examined the expression of IFN receptors, JAKs, STATs, and IFN-inducible genes (MxA, MxB).

Main Results:

  • IFN-inducible genes were upregulated, but MxA and MxB required high IFN-alpha concentrations.
  • Basal expression of IFNAR1, IFNAR2, JAK1, and TYK2 was detectable and unaffected by IFNs.
  • Hepatoma cells had low basal STAT1, STAT2, and p48, but these were strongly upregulated by IFNs.
  • IFN-gamma pretreatment enhanced IFN-alpha-induced ISGF3 complex formation.

Conclusions:

  • Hepatoma cells exhibit positive feedback mechanisms within the IFN signaling system.